GALE.SW Stock — Price, Charts & Analysis

Galenica AG (GALE.SW) has a trailing P/E of 25.60x and a forward P/E of 19.47x. This places GALE.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

GALE.SW trades with 25.60x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether GALE.SW looks overvalued or undervalued.

GALE.SW's P/E of 25.60x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

GALE.SW's trailing EPS is CHF 3.23 and forward EPS is CHF 4.25. Reported earnings growth is -24.90%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Galenica AG generated for each share. GALE.SW's trailing EPS is CHF 3.23, and investors usually prefer EPS that is positive and growing over time.

Galenica AG has a market cap of CHF 4.12B, making GALE.SW a mid-cap stock based on the current market value shown on Worldtickers.

GALE.SW's latest stock price on Worldtickers is CHF 82.70. The latest move is CHF 1.90 or 2.35%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

GALE.SW's quote includes a latest price of CHF 82.70. The market open is CHF 80.95. Previous close is CHF 80.80. The intraday range is CHF 80.60 to CHF 82.70.

GALE.SW is up in the latest quote, with a move of CHF 1.90 or 2.35%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

GALE.SW generated CHF 4.29B in trailing revenue. Revenue growth is 7.00%, which helps show whether demand is expanding or slowing.

GALE.SW's revenue growth is 7.00%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, GALE.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 161.18M.

Gross margin is 12.46%. Margins show how efficiently Galenica AG turns revenue into profit.

Galenica AG carries CHF 1.11B and holds CHF 39.61M in cash.

GALE.SW holds CHF 39.61M on its balance sheet.

GALE.SW's book value per share is CHF 28.30.

Yes, Galenica AG pays a dividend of CHF 2.50 per share annually. The dividend yield is 309.00%. The payout ratio is 77.40%.

GALE.SW's dividend yield is 309.00%. Its payout ratio is 77.40%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for GALE.SW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Galenica AG's investor relations materials.

GALE.SW's five-year average dividend yield is 283.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 52.62% of GALE.SW shares. Insiders hold 0.26% of shares. Ownership mix helps investors understand how much of Galenica AG is held by professional investors and company insiders.

GALE.SW has 49.82M shares outstanding. Float shares are 49.74M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for GALE.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for GALE.SW is CHF 4.25. Earnings growth is -24.90%. Revenue growth is 7.00%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

GALE.SW's trailing EPS is CHF 3.23. Forward EPS is CHF 4.25. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

GALE.SW is in the Healthcare sector. Its earnings multiple is 25.60x. Its latest displayed growth metric is 7.00%. Compare these figures with sector peers before deciding whether Galenica AG is stronger or weaker than average.

GALE.SW trades at CHF 82.70. The stock trades at 25.60x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Galenica AG's fundamentals.

GALE.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.28, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

GALE.SW should be compared with companies in Medical Distribution. Its earnings multiple is 25.60x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Galenica AG (GALE.SW) operates in Healthcare, specifically Medical Distribution. Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sell

GALE.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

GALE.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Galenica AG's official website listed on Worldtickers is www.galenica.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Galenica AG employs about 6.62K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Galenica AG is headquartered in Bern, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

GALE.SW is in the Healthcare sector and the Medical Distribution industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

GALE.SW has traded between CHF 80.30 and CHF 103.00 over the past 52 weeks. At CHF 82.70, it is 19.71% below the high and 2.99% above the low. The 52-week range helps gauge long-term price momentum.

GALE.SW is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is CHF 85.24 and its 200-day moving average is CHF 88.34.

GALE.SW's RSI is 29.15. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a oversold momentum setup.

GALE.SW's latest RSI reading is 29.15, which points to oversold momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for GALE.SW is near CHF 80.30. Key resistance is near CHF 90.30. Breaks above resistance or below support can change the short-term technical setup.

GALE.SW's nearest reported support level is CHF 80.30. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

GALE.SW's nearest reported resistance level is CHF 90.30. A breakout above resistance can improve momentum, especially when volume confirms the move.

GALE.SW trades about 81.53K shares daily on average. The latest displayed volume is 151.57K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

GALE.SW's MACD is -0.40, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

GALE.SW is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 29.15 (oversold). MACD is bearish. Nearest support is around CHF 80.30. Resistance is around CHF 90.30. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 84.15 (-3.98% from price). MA50 is CHF 85.24 (-5.21% from price). MA200 is CHF 88.34 (-8.54% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. GALE.SW's MA20 is CHF 84.15. MA50 is CHF 85.24. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

GALE.SW's pivot is near CHF 81.07. Support is near CHF 80.30. Resistance is near CHF 90.30. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next upper resistance zone is near CHF 81.80. These levels help define risk and possible follow-through zones after a breakout or breakdown.

GALE.SW's Bollinger range is roughly CHF 78.21 to CHF 90.08. Band width is near 14.12%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

GALE.SW's ATR-based typical daily range is about 1.60%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 151.57K shares. Average volume is about 81.53K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

GALE.SW's all-time high shown on Worldtickers is CHF 103.00. Its all-time low is CHF 41.80. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

GALE.SW has a beta of 0.28, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.